We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Clues Link Fat and Colon Cancer

By Biotechdaily staff writers
Posted on 29 May 2002
Researchers have found that the association between high-fat diets and colon cancer may be partly due to the body's inability to cope with a buildup of lithocholic acid, which is highly toxic. More...
The finding was reported in the May 17, 2002, issue of Science.

The body produces bile acids when it breaks down cholesterol, or dietary fat. These bile acids go to the small intestine and are broken down into secondary bile acids, one of which is lithocholic acid. Most secondary bile acids circulate to the liver, but only a small amount of lithocholic acid does so. Much of it remains in the small intestine and then moves into the colon, or large intestine. Here, according to the new finding, the lichocholic acid-controlling receptor is unable to cope with large volumes of lithocholic acid.

The researchers, from the University of Texas Southwestern Medical Center (Dallas, USA), also found that this receptor is similar to another receptor that binds vitamin D to help the body absorb calcium. They discovered that the vitamin D receptor also binds to lithocholic acid, then binds to the CYP3A gene, which triggers production of an enzyme that breaks down the toxic acid.

However, the researchers point out that taking extra vitamin D to stimulate more activity in the vitamin D receptors in order to break down more lithocholic acid would cause the body to absorb more calcium, which could lead to hypercalcemia.

"Lithocholic acid is highly toxic, and it builds up in a high-fat diet,” said Dr. David Mangelsdorf, professor of pharmacology at UT Southwestern. "We don't know how it causes cancer, but it is known to cause cancer in mice, and people with colon cancer have high concentrations of it.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Clinical Informatics Platform
CLARION™
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.